tetano
Editor, Senior Moderator
Acta Neurol Belg
. 2022 Nov 16.
doi: 10.1007/s13760-022-02137-2. Online ahead of print.
A review of the potential neurological adverse events of COVID-19 vaccines
Zeinab Mohseni Afshar[SUP] 1 [/SUP], Akanksha Sharma[SUP] 2 [/SUP], Arefeh Babazadeh[SUP] 3 [/SUP], Ali Alizadeh-Khatir[SUP] 4 [/SUP], Terence T Sio[SUP] 5 [/SUP], Mohamad Ali Taghizadeh Moghadam[SUP] 6 [/SUP], Ali Tavakolli Pirzaman[SUP] 7 [/SUP], Ahmadreza Mojadad[SUP] 7 [/SUP], Rezvan Hosseinzadeh[SUP] 7 [/SUP], Mohammad Barary[SUP] 8 9 [/SUP], Soheil Ebrahimpour[SUP] 10 [/SUP]
Affiliations
Abstract
Despite the advantages of getting access to the coronavirus disease 2019 (COVID-19) vaccines, their potential ability to induce severe adverse events (AEs) has been a significant concern. Neurological complications are significant among the various adverse events following immunization (AEFI) due to their likely durability and debilitating sequelae. Neurological AEs following COVID-19 vaccination can either exacerbate or induce new-onset neuro-immunologic diseases, such as myasthenia gravis (MG) and Guillain-Barre syndrome (GBS). The more severe spectrum of AEs post-COVID19 vaccines has included seizures, reactivation of the varicella-zoster virus, strokes, GBS, Bell's palsy, transverse myelitis (TM), and acute disseminated encephalomyelitis (ADEM). Here, we discuss each of these neurological adverse effects separately.
Keywords: Adverse event; COVID-19; Neurologic; SARS-CoV-2; Vaccine.
. 2022 Nov 16.
doi: 10.1007/s13760-022-02137-2. Online ahead of print.
A review of the potential neurological adverse events of COVID-19 vaccines
Zeinab Mohseni Afshar[SUP] 1 [/SUP], Akanksha Sharma[SUP] 2 [/SUP], Arefeh Babazadeh[SUP] 3 [/SUP], Ali Alizadeh-Khatir[SUP] 4 [/SUP], Terence T Sio[SUP] 5 [/SUP], Mohamad Ali Taghizadeh Moghadam[SUP] 6 [/SUP], Ali Tavakolli Pirzaman[SUP] 7 [/SUP], Ahmadreza Mojadad[SUP] 7 [/SUP], Rezvan Hosseinzadeh[SUP] 7 [/SUP], Mohammad Barary[SUP] 8 9 [/SUP], Soheil Ebrahimpour[SUP] 10 [/SUP]
Affiliations
- PMID: 36385246
- DOI: 10.1007/s13760-022-02137-2
Abstract
Despite the advantages of getting access to the coronavirus disease 2019 (COVID-19) vaccines, their potential ability to induce severe adverse events (AEs) has been a significant concern. Neurological complications are significant among the various adverse events following immunization (AEFI) due to their likely durability and debilitating sequelae. Neurological AEs following COVID-19 vaccination can either exacerbate or induce new-onset neuro-immunologic diseases, such as myasthenia gravis (MG) and Guillain-Barre syndrome (GBS). The more severe spectrum of AEs post-COVID19 vaccines has included seizures, reactivation of the varicella-zoster virus, strokes, GBS, Bell's palsy, transverse myelitis (TM), and acute disseminated encephalomyelitis (ADEM). Here, we discuss each of these neurological adverse effects separately.
Keywords: Adverse event; COVID-19; Neurologic; SARS-CoV-2; Vaccine.